Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:IMRNASDAQ:PBMNYSE:PLXNYSE:RTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIMRiMetal ResourcesC$0.15-3.3%C$0.19C$0.13▼C$0.33C$813K1.5927,451 shs22,111 shsPBMPsyence Biomedical$4.56+3.9%$4.22$2.92▼$699.19$2.60M-0.11103,254 shs30,073 shsPLXProtalix BioTherapeutics$1.56-3.7%$2.39$0.82▼$3.10$124.19M-0.05541,988 shs1.45 million shsRTIRTI International Metals$0.00$0.00▼$0.00N/AN/AN/AN/A20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIMRiMetal Resources0.00%-3.33%+3.57%-29.27%-51.67%PBMPsyence Biomedical0.00%-26.96%+0.18%-54.48%-99.11%PLXProtalix BioTherapeutics0.00%-3.57%-43.16%-31.93%+31.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIMRiMetal ResourcesN/AN/AN/AN/AN/AN/AN/AN/APBMPsyence BiomedicalN/AN/AN/AN/AN/AN/AN/AN/APLXProtalix BioTherapeutics2.7506 of 5 stars3.50.00.00.03.60.01.9RTIRTI International MetalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIMRiMetal Resources 0.00N/AN/AN/APBMPsyence Biomedical 0.00N/AN/AN/APLXProtalix BioTherapeutics 3.00Buy$15.00861.54% UpsideRTIRTI International Metals 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIMRiMetal ResourcesN/AN/AC$0.04 per share3.51C$0.91 per shareN/APBMPsyence BiomedicalN/AN/AN/AN/A($61.61) per shareN/APLXProtalix BioTherapeutics$59.76M2.08$0.09 per share17.80$0.47 per share3.32RTIRTI International MetalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIMRiMetal Resources-C$2.26M-C$0.43N/A∞N/AN/A-37.31%-20.97%N/APBMPsyence Biomedical-$51.16MN/A0.00∞N/AN/AN/AN/AN/APLXProtalix BioTherapeutics$8.31M$0.04N/A5.03N/A-21.03%-30.89%-11.74%N/ARTIRTI International MetalsN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest IMR, RTI, PBM, and PLX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1PLXProtalix BioTherapeuticsN/A-$0.05N/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIMRiMetal ResourcesN/A3.01%N/AN/AN/APBMPsyence BiomedicalN/AN/AN/AN/AN/APLXProtalix BioTherapeuticsN/AN/AN/AN/AN/ARTIRTI International MetalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIMRiMetal Resources0.150.137.79PBMPsyence BiomedicalN/A0.640.64PLXProtalix BioTherapeuticsN/A1.981.27RTIRTI International MetalsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIMRiMetal ResourcesN/APBMPsyence Biomedical77.44%PLXProtalix BioTherapeutics16.53%RTIRTI International MetalsN/AInsider OwnershipCompanyInsider OwnershipIMRiMetal Resources2.57%PBMPsyence Biomedical3.60%PLXProtalix BioTherapeutics6.50%RTIRTI International MetalsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIMRiMetal Resources1405.61 millionN/ANot OptionablePBMPsyence BiomedicalN/A570,0006.36 millionN/APLXProtalix BioTherapeutics20079.61 million69.00 millionOptionableRTIRTI International MetalsN/AN/AN/ANot OptionableIMR, RTI, PBM, and PLX HeadlinesRecent News About These CompaniesLightstorm finishes integrating subsea cables bought from RTIMay 9, 2025 | datacenterdynamics.comRTI INTERNATIONAL METALS (NYSE: RTI) - Share Price and ResearchMay 6, 2025 | intelligentinvestor.com.auRTI International layoffs expected to reach at least 525 by May 1, organization saysMarch 27, 2025 | wral.comRTI International layoff expected to reach at least 525 by May 1, organization saysMarch 27, 2025 | msn.comOpen Source: RTI International CEO makes seven figures. Does that justify USAID cuts?February 21, 2025 | msn.comRTI International to temporarily lay off staff due to US foreign aid freezeFebruary 15, 2025 | wunc.orgRTI International lays off US workers, including in NC, citing Trump’s USAID cutsFebruary 14, 2025 | msn.comRTI International layoffs hit NC due to US freeze on foreign aidFebruary 14, 2025 | wral.comResearch Urges Tyre Particles as Unique Eco ThreatNovember 14, 2024 | miragenews.comA digital exam reels in engraved scenes of Stone Age net fishingNovember 7, 2024 | sciencenews.orgRussia explores creation of international precious metals exchangeOctober 26, 2024 | msn.comRussia in talks with BRICS over precious metals exchangeOctober 24, 2024 | reuters.comRTI Joins the Common Vulnerabilities and Exposures (CVE®) Program as a CVE Numbering Authority (CNA)October 22, 2024 | markets.businessinsider.comRTI Awarded Elite Supplier Status by Lockheed Martin's Rotary and Mission Systems (RMS) DivisionOctober 15, 2024 | tmcnet.comAnalysts Conflicted on These Materials Names: Coeur Mining (CDE), RPM International (RPM) and Rio Tinto Limited (OtherRTNTF)October 10, 2024 | markets.businessinsider.comEnergy transition story rekindles fund interest in metalsOctober 7, 2024 | reuters.comJai Bhim Nagar Demolition: Mumbai Police To File FIR Against BMC Officers And PolicemenOctober 4, 2024 | msn.comRTI International Teams Up with USAID, UNICEF to Create a Lead-Free FutureOctober 4, 2024 | morningstar.comMumbai: BMC Reveals Construction Of Two-Level Underground Parking Lot At Breach Candy In Response To RTI Amid Resident ConcernsOctober 3, 2024 | freepressjournal.inJai Bhim Nagar Demolition: SIT Says Demolition Undertaken Without Any SHRC Order; HC Asks If Police Will Register Cross FIRSeptember 30, 2024 | freepressjournal.inNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBest Defense Stocks in 2025... So FarBy Chris Markoch | April 28, 2025View Best Defense Stocks in 2025... So FarLockheed Martin: A Top Defense Pick in 2025By Jeffrey Neal Johnson | May 16, 2025View Lockheed Martin: A Top Defense Pick in 2025Aerospace and Defense Stocks Take Flight After Strong EarningsBy Leo Miller | April 29, 2025View Aerospace and Defense Stocks Take Flight After Strong EarningsJoby Just Flew Two Aircraft at Once—Here’s Why It MattersBy Jeffrey Neal Johnson | May 14, 2025View Joby Just Flew Two Aircraft at Once—Here’s Why It MattersCAVA's Explosive Growth Makes It a Must-Watch StockBy Gabriel Osorio-Mazilli | May 19, 2025View CAVA's Explosive Growth Makes It a Must-Watch StockIMR, RTI, PBM, and PLX Company DescriptionsiMetal Resources CVE:IMRC$0.14 -0.01 (-3.33%) As of 05/23/2025 03:40 PM EasterniMetal Resources Inc., a junior exploration company, focuses on the acquisition, exploration, development, and evaluation of resource properties in Ontario and Quebec in Canada. The company explores for precious and base metal resources. Its flagship property is the Gowganda West project covering an area of approximately 147 squares kilometers located in Ontario; Kerrs Gold property covering an area of 665 hectares located in Ontario; and Ghost Mountain property consists of eleven claim units covering an area of 220 hectares located in Ontario. The company also holds 100% interest in the Carheil project encompasses approximately 5,400 acres of contiguous land located in the Abitibi region of Quebec. The company was formerly known as Adroit Resources Inc. and changed its name to iMetal Resources Inc. in November 2015. iMetal Resources Inc. was incorporated in 1993 and is headquartered in Vancouver, Canada.Psyence Biomedical NASDAQ:PBM$4.56 +0.17 (+3.87%) Closing price 03:53 PM EasternExtended Trading$4.68 +0.12 (+2.52%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.Protalix BioTherapeutics NYSE:PLX$1.56 -0.06 (-3.70%) Closing price 04:00 PM EasternExtended Trading$1.60 +0.04 (+2.88%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.RTI International Metals NYSE:RTIRTI International Metals, Inc. is a producer and global supplier of titanium mill products and a manufacturer of fabricated titanium and specialty metal components for the national and international aerospace, defense, energy, medical device, and other consumer and industrial markets. The Company operates in two segments: the Titanium segment and Engineered Products and Services (EP&S) segment. The Titanium Segment melts, processes, produces, forges, stocks, distributes, finishes, cuts-to-size, and facilitates just-in-time delivery services of a complete range of titanium mill products, which are further processed by its customers for use in a variety of commercial aerospace, defense, and industrial and consumer applications. The EP&S Segment is comprised of companies with significant hard and soft-metal expertise that form, extrude, fabricate, machine, additively manufacture, micro-machine, and assemble titanium, aluminum, and other specialty metal parts and components. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft's Outlook Brightens as Analysts Boost Bullish Ratings Palantir Scores First $1 Billion Contract; Is It Priced In? Tesla: Why Analysts Think It Could Jump Another 47% Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook 3 Dividend Stocks to Get You Through Tariff Volatility Apple Sinks After New 25% Tariff Announcement—What's The Bottom? MarketBeat Week in Review – 05/19 - 05/23 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
